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After propensity score matching (181 patients per group), 3-year survival was
significantly higher in patients treated with IS.
Conclusions: In a real-world setting of patients admitted with NSTEMI,
the use of IS during the initial hospital stay is an independent predictor of
improved 3-year survival, regardless of age.
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Objectives Coronary artery spasm is an important physiopathological
mechanism in some forms of myocardial ischemic disease. Increased levels of
inflammatory markers and mean platelet volume (MPV) are associated with
increased risk thromboembolism, but the relationship between these parame-
ters and coronary artery spasm is unclear.
Methods During coronary angiography, iv methylergometrin was injected
to 345 patients with chest pain and normal coronary angiograms to provoke
coronary artery spasm. Pts were divided into 2 groups according to results:
spasm group (60 pts) and non-spasm group (285 pts). We compared between
groups: 1) inflammatory markers including C-reactive protein (CRP), white
blood cells (WBC), polymorphonuclear neutrophils (PMN), monocytes (MO),
and lymphocytes (LY); 2) hemostasis markers including mean platelet volume
(MPV), platelet count, fibrinogen (FIB) and D-Dimers (DD); 3) traditional risk
factors for vascular disease, ie. hyperlipidemia, triglycerides (TG), total choles-
terol (TC), LDL and HDL cholesterol (LDL-C, HDL-C) and uric acid (UA).
Results Compared with females, more males with chest pain suffered spasm
during the provocation test (23.56% vs 11.11%, p<0.05). There was no significant
difference in serum levels of LDL-C, HDL-C, TG, TC, LY, MPV and FIB
between groups (p>0.05). Serum levels of CRP and blood counts of PMN and
MO were signicantly higher in the spasm group (P<0.05). Compared with
females, males had a higher frequency of a history of smoking (58.04% vs
46.78%, P<0.05). Logistic regression analysis showed that smoking, PMN and
MO counts were significantly and independently associated with coronary artery
spasm with odds ratios (OR) of 3.52 (1.79-6.90 95% CI, P=0.000), 1.21 (1.07-
1.46 95% CI, P=0.04) and 5.35 (1.37-21.07 95% CI, P=0.01), respectively.
Conclusions Inflammation may contribute to pathogenesis of coronary
artery spasm. Smoking, PMN count and MO count appear to be clinical risk
factors for coronary artery spasm. Conversely, spasm does not seem to be
associated with abnormalities in thrombogenesis.
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Corine Aboa-Eboule (1), Guy-Victor Osseby (1), Yves Cottin (5), Maurice
Giroud (1)
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Aims: Recommendations on the use of antithrombotic agents, antihyperten-
sive drugs and statin for secondary prevention of coronary artery (CAD), isch-
emic cerebrovacular (CVD), and peripheral arterial (PAD) diseases are now well
established. However, there may be a gap between clinical practice and evi-
dence-based guidelines. We aimed to investigate the premorbid use of secondary
prevention medications in patients with recurrent cardiovascular events.
Methods and results: We prospectively recorded all patients with CVD and
CAD in Dijon, France from 2006 to 2010. Data about medical history and prior
use of treatments were collected. Mutivariate analyses were performed to identify
predictors of the use of medications in patients with previous cardiovascular dis-
ease. Among the 2126 patients included (1270 CVD and 856 CAD), 867 (40.8%)
had a history of cardiovascular diseases including 448 (51.7%) with prior CVD
only, 191 (22.0%) with prior CAD only, 68 (7.8%) with prior PAD only, and 160
(18.5%) with polyvascular disease. In these patients, 57.3% were on antithrom-
botic therapy, 61.2% were treated with antihypertensive drugs, 32.9% received
statins, and only 23.6% were on an optimal regimen, defined as the combination
of the three therapies. Compared with patients with previous CAD only, those
with previous CVD only were less likely to be receiving each of these treatments
or to receive an optimal regimen (OR=0.17, p<0.001).
Conclusion: This study highlighted the underuse of recommended sec-
ondary preventive therapies in current clinical practice. Underuse was partic-
ularly pronounced in patients with previous CVD. These findings may account
for the burden of recurrent events.
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Objective Platelet activation is present in atrial fibrillation (AF), but there is
some debate whether this is due to AF itself and/or to underlying cardiovascular
diseases. We aim to determine the association between a marker of platelet reac-
tivity (mean platelet volume (MPV)) and systemic inflammation (CRP) mea-
sured on admission, and new onset episode of AF in patients with MI.
Patients and methods Prospective cohort of 4994 consecutive patients
with AMI. Patients with paroxysmal or persistent AF were excluded.
Results 426 (8.5%) patients were diagnosed with a new onset of AF during
the in-hospital-stay (mean stay 3±2 days). These patients were older (75 vs 65,
p<0.001), predominantly male, and prevalence of hypertension and diabetes was
greater. Also less smoker were found among this group. Despite similar reper-
fusion strategies, clinical presentation with heart failure and increased heart rate
(HR) was more frequently found in patients with AF. Left ventricular ejection
fraction (LVEF) was significantly depressed in AF patients (47 vs. 55, p<0.001),
among with increased NT-proBNP, admission MPV (8.9 vs. 8.6, p<0.001) and
CRP (10.7 vs 5.7, p<0.001). Backward logistic regression analysis (model 1)
found that age [OR=1.04, 95%CI (1.031-1.050), p<0.001)], HR [OR=1.016,
95%CI (1.011-1.021), p<0.001)], LVEF [OR=0.979, 95%CI (0.970-0.987),
p<0.001)] and MPV [OR=1.182, 95%CI (1.064-1.312), p<0.001)] were inde-
pendent predictors of AF occurrence. A second backward regression analysis
(model 2= model 1+CRP) found that age [OR=1.036, 95%CI (1.026-1.046),
p<0.001)], HR [OR=1.013, 95%CI (1.008-1.018), p<0.001)], LVEF [OR=0.977,
95%CI (0.968-0.987), p<0.001)] and CRP [OR=1.003, 95%CI (1.001-1.005),
p=0.006)] were independent predictors of AF occurrence after MI.
Conclusions This study suggested that new onset of AF early after MI is
rather linked to inflammation induced by myocardial damage or the existing
atherosclerotic burden than platelet activation.
016
Evidence of systemic plaque vulnerability in acute coronary syndromes
with FDG-positron emission tomography and computed tomographic
angiography in the BIOCORE-2 study
Fabien Hyafil (1), Valérie Duchatelle (2), Lotfi Mehanaoui (2), François
Rouzet (1), Emmanuel Sorbets (1), Olivier Lairez (1), Olivier Meilhac (3),
Gabriel Steg (2), Dominique Le Guludec (1), Laurent Feldman (2)
(1) CHU Bichat, Médecine ucléaire, Paris, France – (2) CHU Bichat,
Cardiologie, Paris, France – (3) Inserm 698, CHU Bichat, Paris, France
© Elsevier Masson SAS. All rights reserved.
 
6 Archives of Cardiovascular Diseases Supplements (2013) 5, 1-18
Purpose: Atherosclerotic plaque vulnerability is a systemic phenomenon
and is often associated with severe plaque infiltration with inflammatory cells.
18-Fluoro-deoxyglucose (FDG) accumulates in inflammatory cells of athero-
sclerotic plaques. The aim of this study was to assess whether 1) FDG uptake
in the aorta and carotid arteries measured by positron emission tomography
(PET) is higher in patients with acute coronary syndromes (ACS) than in
patients with stable coronary artery disease (CAD) and; 2) associated with
morphological markers of plaque instability detected with computed tomo-
graphy angiography (CTA).
Methods: Patients with ACS (n=50) or stable CAD (n=28) underwent a
PET 90 minutes after injection of 5 MBq/kg FDG followed by a CTA of the
thoracic aorta and carotid arteries. Tissue-to-background ratios (TBRs) were
calculated by dividing maximal standard uptake value (SUV) of the arterial
wall by the mean SUV of blood. A global TBR was calculated in each patient
as the average of the TBRs from the thoracic aorta and the 2 carotid arteries.
Atherosclerotic plaques were classified with CTA as non-calcified/mixed/cal-
cified, and smooth/irregular.
Results: Aortic, carotid and global TBRs (mean±SD) were higher in
patients with ACS than in patients with stable CAD (1.78±0.19 vs. 1.61±0.18;
1.84±0.35 vs. 1.64 ±0.17; 1.81±0.23 vs. 1.62±0.16; p<0.05 for all). Patients in
the highest quartile of global TBR had a higher percentage of non-calcified
and irregular plaques in the thoracic aorta and carotid arteries as compared to
patients in the lowest quartile of global TBR (cf. Table 1).
Conclusions: FDG uptake in the thoracic aorta and carotid arteries is
higher in patients with ACS than in patients with stable CAD and correlates
with morphological markers of plaque instability assessed by CTA.
Table 1 – Results
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Echocardiographic factors determining immediate results of percuta-
neous mitral balloon commissurotomy
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Objectives: Define echocardiographic predictors of the immediateresults
of percutaneous mitral balloon commissurotomy (PMC)
Methods : PMC by the Inoue balloon was attempted in 247 patients (mean
age: 35 ans, 77% female) with severe mitral valve stenosis. All the patients
had undergone echocardiographic examination before PMC to assess mitral
anatomy, commissural calcification and to determine the Wilkins score.
Results: the mean value of Wilkins score was 7,98±1,61(range 5-13) and
the mean mitral valve area (MVA) before PMC was 1±0,19cm² (range 0,5-
1,4cm²). Twenty-nine patients (11,7%) had one-commissural calcification.
After PMC, the mean MVA increased to 1,79±0,34cm² (p<0,001) resulting in
a success rate of 83%. Severe mitral regurgitation (MR) occured in 5 patients
(2%). Wilkins score was an independent predictor of the immediate result of
PMC, but if >8, this score had a weak predictive value. Commissural mor-
phology was another independent predictor of the immediate result of PMC.
Conclusion: Echocardiography is now the cornerstone in the assessment of
mitral anatomy before PMC and should integrate Wilkins score and commis-
sural morphology for the optimal selection of patients to PMC.
*This abstract refered to topic “Valvular heart disease”.
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Background: Acute complications of atherosclerosis, such as acute myo-
cardial infarction (AMI) are becoming more common in patients with HIV.
But the risk of coronary heart disease in HIV patients is influenced both from
traditional risk factors and from specific features of this disease. The aim of
the present study was to examine in-hospital case fatality in HIV-infected
patients with AMI.
Methods: From the French nationwide hospital medical information data-
base, data for all the consecutive patients hospitalized in the 1546 French hos-
pital/clinics for AMI from 1st January 2005 to 31st December 2009 were
analysed. Patients were match according
following parameters: age, gender, type of infarction (ratio 1:2).
Findings: Among the 677 076 patients included, HIV-infected patients
(n=1344) accounted for 0.20%. HIV patients were younger, more frequently
male and more likely to smoke. Hospital mortality was 4.3% in the HIV-
infected group compared with 7.0% in uninfected patients (p <0.0001), but no
difference appeared between the 2 groups after matching (3.4% vs. 4.3%;
p=0.1334). Based on a Cox regression model, HIV-infection was not an inde-
pendent predictor of in-hospital mortality in the overall population or after
matching. Among none HIV infected patients, dyslipidemia, current smoker,
STEMI and coronary angioplasty were independent predictors of in-hospital
mortality. In contrast, among HIV infected patients, dyslipidemia [OR-95%IC:
0.356 (0.141-0.903)], renal failure [OR-95%IC: 2.433 (1.174-5.044)] and
STEMI [OR-95%IC: 2.130 (1.113-4.076)] were independent factors were
associated with in-hospital mortality.
Conclusion: HIV-infected patients have a greater risk of myocardial
infarction, but the present study demonstrated than the short-term are similar
to non infected patients. Moreover, chronic kidney disease is more common in
HIV-infected patients and associated with a worse prognosis. Consequently
HIV care increasingly needs to incorporate strategies to manage these non-
infectious co-morbidity in primary and secondary prevention.
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Background: The national observational study of diagnostic and interven-
tional cardiac catheterization (ONACI) is a prospective multi-center registry
of the French Society of Cardiology including all interventional cardiology
procedures performed from 2004. We aimed to evaluate “real world” manage-
ment of patients with coronary artery disease (CAD) in France from this
registry.
Methods: The present study is focused on data collected between 2004 and
2008. Patient demographics and co-morbidities, invasive parameters, treat-
ment options, and procedural techniques were prospectively collected. Patients
were recruited in 99 hospitals (55% of patients were hospitalized in private
clinics, 45% in public institutions).
Total 
number 
of 
plaques
Global 
TBR 
values
Patients 
with 
ACS
on 
calcified
MixedCalcifiedSmooth Irregular
First 
quartile
53 1.36-1.60 32% 30% 45% 25% 100% 0%
Second 
quartile
70 1.61-1.70 63% 43% 37% 20% 94% 6%
Third 
quartile
55 1.71-1.81 74% 39% 47% 14% 87% 13%
Forth 
quartile
58 1.82-2.75 85% 40% 57 % 3% 88% 12%
